| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.087 | 0.2 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |